CaroGen Corporation
Overview
CaroGen Corporation leads in immunotherapy and vaccine development, using its RNA-based AVIDIO platform for cancer and hepatitis B therapies, backed by NIH and DoD funding.
Related on NestLens
Last updated July 15, 2026
CaroGen Corporation leads in immunotherapy and vaccine development, using its RNA-based AVIDIO platform for cancer and hepatitis B therapies, backed by NIH and DoD funding.
Last updated July 15, 2026